Vividion Therapeutics Funding: $362M Raised, Series B (2019)
Vividion Therapeutics is a Biotech company based in San Diego. It has raised $362M in total funding. Latest round: Series B.
Vividion Therapeutics funding overview
Vividion Therapeutics is a Biotech company based in San Diego. Vividion Therapeutics has raised $362M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series B announced in January 2019. The round record for Vividion Therapeutics runs through 2019; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Versant Ventures, Cardinal Partners, Celgene Corporation, Nextech Invest, Alexandria Venture Investments and 12 others. 18 distinct backers are named across the disclosed rounds.
Frequently asked about Vividion Therapeutics funding
How much has Vividion Therapeutics raised?
Vividion Therapeutics has raised $362M in total disclosed funding across the rounds on record.
Who has invested in Vividion Therapeutics?
ARCH Venture Partners, Versant Ventures, Cardinal Partners, Celgene Corporation, Nextech Invest, Alexandria Venture Investments are named among the investors backing Vividion Therapeutics.
What was the latest Vividion Therapeutics funding round?
The most recent disclosed round is a Series B, announced in January 2019.
Where is Vividion Therapeutics based?
Vividion Therapeutics is based in San Diego.
What sector does Vividion Therapeutics operate in?
Vividion Therapeutics is tracked under Biotech from San Diego, with $362M in disclosed funding.
When did Vividion Therapeutics last raise?
The last disclosed Vividion Therapeutics round closed in January 2019 at Series B.
Every Vividion Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies in San Diego at a similar stage.
